Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Care-Bio is a specialized life sciences company based in China that provides a dual-track of clinical research services and advanced single-cell analysis technologies. Founded in 2010, the company's CRO division is a leader in the regulatory and clinical trial space for In Vitro Diagnostics (IVD) and medical devices, assisting global and domestic firms with NMPA registrations. In 2016, the company launched its biotech division, Care-Bio (Suzhou), which focuses on the development of high-throughput single-cell sequencing platforms. Their flagship CareCell system utilizes microfluidic technology and proprietary bioinformatics to enable large-scale transcriptomic and genomic analysis at the single-cell level. Care-Bio's integrated approach supports the entire drug and diagnostic development lifecycle, from basic research and biomarker discovery to clinical validation and market entry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Care-Bio.